GW Pharmaceuticals PLC Holding(s) in Company (9985P)
November 24 2016 - 2:30AM
UK Regulatory
TIDMGWP
RNS Number : 9985P
GW Pharmaceuticals PLC
24 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or GW Pharmaceuticals PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- -------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------- ---------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------------- ---------------------------------
An acquisition or disposal of instruments with x
similar economic effect to qualifying financial
instruments
----------------------------------------------------------------- ---------------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------------- ---------------------------------
Other (please
specify):
--------------------------------------------------------- ------ ---------------------------------
3. Full name of person(s) The Goldman Sachs Group, Inc.
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------------
4. Full name of shareholder(s) Goldman Sachs International
(if different from 3.):(iv) Goldman, Sachs & Co.
Goldman Sachs Asset Management,
L.P.
----------------------------------------------------------- ---------------------------------------
5. Date of the transaction 18 November 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------------
6. Date on which issuer 22 November 2016
notified:
----------------------------------------------------------- ---------------------------------------
7. Threshold(s) that is/are Below 3%
crossed or
reached: (vi, vii)
----------------------------------------------------------- ---------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------- ------------------------------ ----------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
---------------- -------------- -------------- -------- ----------------------- -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
---------------- -------------- -------------- -------- ------- -------------- ------- --------------
Below Below
GB0030544687 94,532 94,532 3% 3%
-------------- -------------- -------- ------- -------------- ------- --------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- -------------- ------------------------ ----------------------- -----------------------
Below 3% Below 3%
---------------- -------------- ------------------------ ----------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
(xv, xvi)
----------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number % of voting
instrument price date Conversion of voting rights (xix,
period rights xx)
instrument
refers
to
------------------ --------- ----------- ------------ ------------ ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------ -------- ------
Below Below
3% 3%
------------------ --------- ----------- ------------ ------------ -------- ------
------------------------------------------------------------------------------------------------------------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------ ----------------------------------------------------------
Below 3% Below 3%
------------------------------------------------ ----------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------------
N/A
Proxy Voting:
----------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
------------------------------------------------------- -------------------------------
11. Number of voting rights proxy N/A
holder will cease
to hold:
------------------------------------------------------- -------------------------------
12. Date on which proxy holder will N/A
cease to hold
voting rights:
------------------------------------------------------- -------------------------------
General email contact:
13. Additional information: shareholderdisclosures@gs.com
------------------------------------------------------- -------------------------------
14. Contact name: Joanna Foley
------------------------------------------------------- -------------------------------
15. Contact telephone number: +44 207 051 9996
------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPFDAEAKFFF
(END) Dow Jones Newswires
November 24, 2016 02:30 ET (07:30 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Apr 2024 to May 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From May 2023 to May 2024
